Index

Acceptance and commitment therapy (ACT),

150

ACT

. See Acceptance and commitment therapy

ADHD

. See Attention-deficit/hyperactivity disorder

Adjustment disorder with depressed mood, medication trials and case reports for OCPD and,

192

Age

childhood traits of OCPD,

54

children with obsessive difficult temperament,

208

at onset of OCPD,

10, 110, 116

positive aspects of conscientiousness,

237–239

Aggression, OCPD and,

99–107

biological features of OCPD with and without aggression,

102–104, 106

case vignette,

99–100, 105–106

inflammatory proteins and,

103

neuroimaging studies of,

103–104, 104

measures of aggression,

101, 102

measures of impulsivity,

101–102, 102

serotonin and,

102–103

treatment considerations,

105

Agoraphobia

medication trials and case reports for OCPD and,

194

with OCPD,

13

Alcohol dependence, medication trials and case reports for OCPD and,

194

α-amylase,

131

Alzheimer’s dementia, medication trials and case reports for OCPD and,

190–191

AN

. See Anorexia nervosa

Anal-erotic character style traits,

3, 51

Anankastia,

17. See also Obsessive-compulsive personality disorder

description of,

2

diagnostic criteria in DSM-III,

29

ICD-11 definition of,

35

ICD diagnostic criteria for anankastic personality disorder,

32

OCPD traits in,

38–39

Anorexia nervosa (AN),

74

atypical,

78

medication trials and case reports for OCPD and,

185–186

OCPD and,

74–75

Antiepileptics, for treatment of OCPD,

210. See also individual drug names

Antipsychotics, for treatment of OCPD,

208–209, 211–212

first-generation,

208–209

second-generation,

209

Antisocial personality disorder,

224

Anxiety disorders, with OCPD,

13

ARFID

. See Avoidant/restrictive food intake disorder

Aripiprazole, medication trials and case reports for OCPD and BPD,

186

Attachment theory,

221, 228

OCPD and,

221

parenting capacity of parents with personality disorders and,

221–223

Attention-deficit/hyperactivity disorder (ADHD)

medication trial and case reports for OCPD and,

193

misdiagnosis of,

xiii

OCPD and,

90

Atypical anorexia nervosa,

78

Avoidant personality disorder, medication trial and case reports for OCPD and,

194

Avoidant/restrictive food intake disorder (ARFID),

77–78

Barratt Impulsiveness Questionnaire,

92

Barratt Impulsiveness Scale (BIS-11),

91, 101

BED

. See Binge-eating disorder

Binge-eating disorder (BED),

76–77, 89

of low frequency and/or limited duration,

78

OCPD and,

12, 77

rates of OCPD and,

90

Bipolar affective disorders

medication trial and case reports for OCPD and,

190

with OCPD,

13

BIS-11

. See Barratt Impulsiveness Scale

BMI

. See Body mass index

BN

. See Bulimia nervosa

Body dysmorphic disorder, medication trial and case reports for OCPD and,

196

Body mass index (BMI),

72

Bonferroni correction,

234

Borderline personality disorder (BPD),

224. See also Cluster B personality disorders

medication trials and case reports for OCPD and,

186–187

Bowlby, John,

221

BPAQ

. See Buss-Perry Aggression Questionnaire

BPD

. See Borderline personality disorder

Brain, OCPD-related personality traits and,

136

Brown Longitudinal Obsessive Compulsive Study,

55

Bulimia nervosa (BN),

75–76

Cluster B and C personality disorders and,

76

of low frequency and/or limited duration,

78

OCPD and,

76

Buspirone

medication trials and case reports for OCPD

and compulsive buying,

197

and OCD,

197, 199

Buss-Perry Aggression Questionnaire (BPAQ),

101

California Child Q-Set (CCQ),

237

Cambridge Gambling Task,

92

Carbamazepine

medication trial and case reports for OCPD diagnosis,

181

for treatment of OCPD,

210, 212

Case vignettes

aggression and OCPD,

99–100, 105–106

clinical features of OCPD,

27–28

cultural aspects of OCPD,

110, 122

eating disorder with OCPD,

71–72

gender and OCPD,

109, 122

hoarding disorder and OCD,

50–52

impact of personality disorders on parenting,

217–218

impulsivity-control disorders,

85–86, 93

OCD,

49–50, 127–128

OCPD with depression,

1–2

perfectionism,

143–144, 150–165

pharmacological treatment for OCPD,

179–180

positive aspects of OCPD,

233–234, 240–241

psychobiology of OCPD,

127–128

psychotherapy for OCPD,

143–144, 150–165

sexual behavior,

85–86, 93

CBT

. See Cognitive-behavioral therapy

CCQ

. See California Child Q-Set

CFI

. See Cultural Formulation Interview

CGI

. See Clinical Global Impressions Scale

Change, definition of difficulty with,

171

Childhood Retrospective Perfectionism Questionnaire (CHIRP),

54–55

Children

. See also Parents

childhood traits of OCPD,

54

impact of parental personality disorder on child development and mental health,

223–226

with obsessive difficult temperament,

208

positive aspects of conscientiousness in youth,

237–239

CHIRP

. See Childhood Retrospective Perfectionism Questionnaire

Cisgender females, definition of,

111

Cisgender males, definition of,

111

Citalopram

medication trials and case reports for OCPD

and avoidant personality disorder,

194

and MDD,

183, 195

and OCD,

194

and Tourette’s disorder,

194

and trichotillomania,

194

for treatment of OCPD,

205–206, 211

Clinical Global Impressions Scale (CGI),

209

Clinical perfectionism,

155–156, 166

CBT model of,

157

Clinical Perfectionism Questionnaire (CPQ),

36

Clomipramine

medication trials and case reports for OCPD

and ADHD,

193

and adjustment disorder with depressed mood,

192

and eczema,

191

and generalized anxiety disorder,

191

and insomnia,

191–193

and migraines,

191

and oppositional defiant disorder,

192

and panic disorder,

192

for treatment of OCPD,

57, 207–208

Cloninger’s model of personality traits,

133

Clovoxamine

medication trial and case reports for OCPD and MDD,

188

for treatment of OCPD,

207

Cluster A personality disorders,

116, 218–219

Cluster B personality disorders,

76, 116, 219. See also Borderline personality disorder

Cluster C personality disorders,

2, 62, 116, 129, 180, 202, 219

bulimia nervosa and,

76

neuroimaging and molecular studies of,

130–131

Clutter,

15, 52, 60–62, 153. See also Hoarding disorder

Cognition

conscientiousness and,

236–237

deficits associated with impulsivity,

93

OCPD studies and,

130

positive associations with OCPD,

234–236

research on,

235

Cognitive-behavioral therapy (CBT)

for clinical perfectionism and rigidity,

151, 161–165

model of clinical perfectionism,

156–157

research for OCPD,

148–150

for treatment of aggression with OCPD,

106

for treatment of HD,

63

for treatment of OCD,

57

Collaborative Longitudinal Personality Disorders Study,

55, 57, 219

Compulsive buying

medication trials and case reports for OCPD and,

195, 197–199

rates of OCPD and,

89, 90

Compulsive Personality Assessment Scale (CPAS),

13–1514

Compulsive personality disorder, in DSM-III,

3–4

Compulsivity,

86–88

Conscientiousness

career success and,

240, 241

case vignette,

233–234, 240–241

cognition and,

236–237

in older age groups,

239

resilience and,

239–240

in youth through middle age,

237–239

Cortisol,

131

CPAS

. See Compulsive Personality Assessment Scale

CPQ

. See Clinical Perfectionism Questionnaire

C-reactive protein (CRP),

103

CRP

. See C-reactive protein

Cultural Formulation Interview (CFI),

112

Culture

approaches to gender and culture in DSM-IV and DSM-5,

112

case vignettes,

109–110, 122

in DSM-5,

111

OCPD and,

109–125

personality and,

117–118

personality disorder and,

118–120

DBT

. See Dialectical behavior therapy

Death Anxiety Questionnaire,

146

Delegation, reluctance with

definition of,

171

as feature of OCPD,

42

Depressive disorders and OCPD,

12–13

case vignette,

1–2

DERS

. See Difficulties in Emotion Regulation Scale

d-FEN

. Seed-fenfluramine

Diagnostic and Statistical Manual (DSM)

categorical classification of OCPD,

29–30, 30

definition of OCPD,

3–4

DSM-I

definition of OCPD,

3

DSM-II

definition of OCPD,

3

diagnostic criteria for OCPD,

29

DSM-III

definition of OCPD,

3–4

diagnostic criteria for OCPD,

149–150

diagnostic criteria for anankastic personality disorder,

30

diagnostic criteria for OCPD,

29

OCPD traits in,

38–39

systematic prevalence analysis of OCPD,

7–8

DSM-III-R

assessment of OCPD in community populations,

5

definition of OCPD,

4

OCPD traits in,

38–39

systematic prevalence analysis of OCPD,

7–8

DSM-IV

approaches to gender and culture in,

112

diagnostic criteria for OCPD,

29–31, 149

diagnostic criteria for OCPD and OCD,

60

diagnostic threshold of OCPD,

4

OCPD traits in,

38–39

studies of OCPD,

5

systematic prevalence analysis of OCPD,

8–9

DSM-5

alternative model for personality disorders,

17, 31–33, 34, 37, 38–39, 43, 218–219

approaches to gender and culture in,

112

definition of personality disorders,

2

diagnostic criteria for OCPD,

4, 29–31, 30, 33, 100, 145, 152–153

diagnostic criteria for personality disorders,

32–33, 100

proposed diagnostic criteria,

34

hybrid personality model,

114

OCPD traits in,

38–39

Diagnostic Interview for DSM-IV Personality Disorders (DIPD-IV),

36

Diagnostic Interview for Personality Disorders (DIPD),

13

Dialectical behavior therapy (DBT),

150

Difficulties in Emotion Regulation Scale (DERS),

154, 155

DIPD

. See Diagnostic Interview for Personality Disorders

DIPD-IV

. See Diagnostic Interview for DSM-IV Personality Disorders

Discounting,

91, 92, 130, 235

DSM

. SeeDiagnostic and Statistical Manual

Dysthymic disorder, medication trial and case reports for OCPD and,

193

Eating Disorder Inventory—Perfectionism scale (EDI-P),

186, 204

Eating disorder not otherwise specified (EDNOS),

78–79

Eating disorders

anorexia nervosa,

74

avoidant/restrictive food intake disorder,

77–78

binge-eating disorder,

76–77, 89

bulimia nervosa,

75–76

case vignette,

71–72

eating disorder not otherwise specified,

78–79

future directions for research,

79–80

genetic influence on,

75

night eating syndrome,

78

with OCPD,

12

other specified feeding or eating disorder,

78

purging disorder,

78

Eczema, medication trials and case reports for OCPD and,

191

EDI-P

. See Eating Disorder Inventory—Perfectionism scale

EDNOS

. See Eating disorder not otherwise specified

Ego-dystonic symptoms, of OCPD and OCD,

53

Emotional overcontrol, definition of,

171

Escitalopram

medication trial and case reports for OCPD and OCD,

189

for treatment of OCPD,

206

Ethnicity

definition of,

111

OCPD and,

120

Excoriation,

89

rates of OCPD and,

90

Exposure response prevention,

93

EX/RP, for treatment of OCD,

57–58

Family history

. See also Genetics

linkage between OCPD and OCD,

54

of OCPD,

10–11

psychobiology of family studies of OCPD,

128–129

Fenfluramine, medication trial and case reports for OCPD and OCD,

200

d-fenfluramine (d-FEN),

103

FFM

. See Five-factor model of personality

FFOCI

. See Five Factor Obsessive-Compulsive Inventory

FGAs

. See First-generation antipsychotics

First-generation antipsychotics (FGAs), for treatment of OCPD,

208–209

Five-factor model (FFM) of personality,

16–17, 32–33, 113, 117, 132, 236

Five Factor Obsessive-Compulsive Inventory (FFOCI),

36

5HTTLPR

. See Serotonin transporter promoter polymorphism

Fluoxetine

medication trials and case reports for OCPD

and agoraphobia,

194

and alcohol dependence,

194

and AN,

185

and body dysmorphic disorder,

196

and compulsive buying,

198

and dysthymic disorder,

193

and MDD,

187–188

and OCD,

195–200

and panic disorder,

194

and pathological gambling,

197

and trichotillomania,

197

for treatment of aggression with OCPD,

106

for treatment of OCPD,

202–203

Fluvoxamine

medication trials and case reports

for OCD diagnosis,

181

for OCPD and compulsive buying,

198

for OCPD and OCD,

198

for treatment of OCPD,

203–204, 210–211

fMRI

. See Functional magnetic resonance imaging

Freud, Sigmund,

3

Frost Multidimensional Perfectionism Scales,

15

Functional magnetic resonance imaging (fMRI),

103–104, 130–131, 133. See also Neuroimaging

Gambling disorder,

89

medication trials and case reports for OCPD and,

195, 197

rates of OCPD and,

90

Gender

approaches to culture and gender in DSM-IV and DSM-5,

112

case vignette,

109, 110, 122

definition of,

111

OCPD and,

109–125, 114–117

personality and,

112–113

personality disorders and,

113–114

versus sex,

111

Generalized anxiety disorder, medication trials and case reports for OCPD and,

189, 191

Genetics

. See also Family history

familial link between OCPD and OCD,

54

family studies of OCPD,

128–129

gender and OCPD,

115–117

heritability of personality traits,

134

influence on eating disorders,

75

as risk factor for personality disorders,

225–226, 228

twin studies of OCPD,

129

Genome wide-association studies (GWAS),

131–132, 134

Good enough parenting,

220

GWAS

. See Genome wide-association studies

Hair-pulling disorder,

89

rates of OCPD and,

90

Haloperidol

medication trials and case reports for OCPD

and Alzheimer’s dementia,

190–191

and bipolar disorder,

190

and OCD,

194

and schizophrenia,

190–191

and Tourette’s disorder,

194

HD

. See Hoarding disorder

Hoarding disorder (HD),

4, 51, 60–61. See also Obsessive-compulsive and related disorders

case vignette,

49–50, 51–52

medication trial and case reports for OCPD and,

182

OCPD and,

60–64

comorbidity and correlates,

62–63

future directions for research,

64

symptoms, core components, and differential diagnosis of,

60–62

treatment implications,

63–64

theoretical model of overlap between OCPD, OCD and,

56

Hoarding Rating Scale—Interview,

15

Hoarding Rating Scale—Self-Report,

15

Hypersentimentality,

61. See also Hoarding disorder

ICD

. See International Classification of Diseases

IED

. See Intra-Extra Dimensional task

IIP-SC

. See Inventory of Interpersonal Problems—Short Circumplex

IL-6

. See Interlukin-6

Imipramine

medication trial and case reports for OCPD and MDD,

188

for treatment of OCPD,

208

Impulsivity

description of,

86

measures of aggression and,

101–102, 102

and OCPD,

90–93

Impulsivity-control disorders

case vignette,

85–86, 93

in individuals with OCPD,

90–93

OCPD and,

88–89

rates of,

90

relationship to OCPD,

89–90

Inflexibility, as feature of OCPD,

42

Insomnia, medication trials and case reports for OCPD and,

191–193

Interlukin-6 (IL-6),

103

Intermittent explosive disorder (IED),

101, 103

International Classification of Diseases (ICD)

categorical classification of OCPD,

31

diagnostic criteria for anankastic personality disorder,

32, 43

evolution of OCPD,

xiii–xiv

ICD-10, OCPD traits in,

38–39

ICD-11

classification of personality disorders in,

33–35

definition of anankastia,

35

dimensional model of personality disorder assessment,

2

OCPD traits in,

38–39

proposals for,

17

International Personality Disorder Examination (IPDE),

13, 36, 116

Internet addiction, rates of OCPD and,

90

Interpersonal relationships, with OCPD,

11

Inventory of Interpersonal Problems—Short Circumplex (IIP-SC),

153, 154, 155

IPDE

. See International Personality Disorder Examination

Kleptomania, rates of OCPD and,

90

Level of Personality Functioning Scale (LPFS),

37

Level of Personality Functioning Scale—Brief Form 2.0 (LPFS-BF),

37

LHA

. See Life History of Aggression

LHIB

. See Life History of Impulsive Behavior

Life history, framework of,

135–136

Life History of Aggression (LHA),

101

Life History of Impulsive Behavior (LHIB),

101

LPFS

. See Level of Personality Functioning Scale

LPFS-BF

. See Level of Personality Scale—Brief Form 2.0

Major depressive disorder (MDD), medication trials and case reports for OCPD and,

183, 187–188, 195

Maladaptive perfectionism,

53, 65, 146, 171

Marriage

. See also Parents

case vignette of OCPD, gender and,

109

hoarding disorder case vignette and,

50–51

Maternal somatization disorder,

225

MCMI-III

. See Millon Clinical Multiaxial Inventory–III

MDD

. See Major depressive disorder

Metacognitive therapy,

150

Migraines, medication trials and case reports for OCPD and,

191, 193

Millon Clinical Multiaxial Inventory–III (MCMI-III),

15–17, 36

Mindfulness meditation,

128

Minnesota Multiphasic Personality Inventory–2 (MMPI-2),

36

Miserliness,

17

MMPI-2

. See Minnesota Multiphasic Personality Inventory–2

Models

CBT model of clinical perfectionism,

156, 156–157

of clinical perfectionism,

166

Cloninger’s model of personality traits,

133

dimensional models of OCPD,

31–35

five-factor model of personality,

16–17, 32–33, 113, 117, 132, 236

of good enough parenting,

220

hybrid personality model in DSM-5,

114

ICD-11 dimensional model of assessment,

2

theoretical model of overlap between OCPD, OCD, and HD,

56

threshold versus dimensional models of OCPD,

16–18

Molecular studies, of OCPD,

130–132

Mood stabilizers

. See Carbamazepine

Naltrexone,

93

National Comorbidity Survey Replication,

72

National Epidemiologic Survey on Alcohol and Related Conditions (NESARC),

115, 120

on rates of OCPD,

xiii

National Institute of Mental Health Global Obsessive-Compulsive Scale,

213

Negative affective states, as feature of OCPD,

3

NEO Personality Inventory—Revised (NEO PI-R),

116, 236

NEO PI-R

. See NEO Personality Inventory—Revised

NESARC

. See National Epidemiologic Survey on Alcohol and Related Conditions

Neuroimaging

. See also Functional magnetic resonance imaging

in studies of aggression,

103–104

studies of Cluster C personality disorders,

130–131

studies of OCPD,

103–104, 104, 130–132

Neuroticism,

132–133

Night eating syndrome,

78

Nonbinary/gender-queer individuals, definition of,

111

Noncisgender females, definition of,

111

Noncisgender males, definition of,

111

OBQ

. See Obsessive Belief Questionnaire

Obsessive Belief Questionnaire (OBQ),

59

Obsessive-compulsive and related disorders (OCRDs),

2. See also Hoarding disorder

Obsessive-compulsive disorder (OCD)

case vignettes of,

49–50, 127–128

medication trials and case reports for OCPD and,

184, 189, 194–195, 197–201

misdiagnosis of,

xiii

versus OCPD,

37, 41–42

OCPD and,

52–59, 86–87, 136

characterization of,

52

comorbidity and correlates,

55–57, 56

courses of OCD and OCPD,

54–55

family history linkage,

54

longitudinal studies of,

55

symptoms, core components and differential diagnosis of,

52–54

treatment implications,

57–59

phenomenology of,

40

probands with,

128

theoretical model of overlap between OCPD, HD and,

56

Obsessive-compulsive personality disorder (OCPD)

. See also Anankastia

ADHD and,

90

aggression and,

99–107

agoraphobia and,

13

anorexia nervosa and,

74–75

anxiety disorders and,

13

assessment of,

35–37, 43

attachment theory and,

221

biological features of OCPD with and without aggression,

102–104

bipolar affective disorders and,

13

case vignettes

aggression and OCPD,

99–100, 105–106

clinical features of OCPD,

27–28

depression with OCPD,

1–2

hoarding disorder and,

50–52

categorical classification of,

29–31

in DSM,

29–30, 30

in ICD,

31

characterization of,

43, 86, 100

childhood traits of,

54

classification of,

86

clinical features of,

37–42

cognition and,

130

compulsivity in individuals with,

87–88

core features and functional impairment associated with,

145–147, 148

definitions of

in DSM,

3–4

in DSM-IV,

28–29

depressive disorders and,

12–13

diagnostic criteria

in DSM-II,

29

in DSM-III,

149–150

in DSM-IV,

149

in DSM-5,

4, 29–31, 30, 33, 43, 145

dimensional models of,

31–35

in DSM-5,

32–33

eating disorders and,

71–80

evolution of,

xiii–xiv

gender and cultural aspects of,

109–122

history and epidemiology of

age at onset,

10

assessment of,

5, 13, 14, 15

case vignette,

1–2

characterization of OCPD,

2, 17

comorbidity,

12–13

diagnostic efficiency and stability,

15–16

family history and,

10–11

impact of,

11

origins of the diagnosis,

3

prevalence of,

4–6

systematic prevalence analysis,

6, 7–9

hoarding disorder and,

60–64

comorbidity and correlates,

62–63

future directions for research,

64

symptoms, core components, and differential diagnosis of,

60–62

treatment implications,

63–64

ICD-11 classification of personality disorders,

33–33

impulse-control disorders and,

88–89, 90–93

rates of,

90

interpersonal relationships and,

11

NESARC survey on rates of,

xiii

nosology of,

2, 17–18, 28–29

versus obsessive-compulsive disorder,

37, 41–42

OCD and,

52–59, 86–87, 136

characterization of,

52

comorbidity and correlates,

55–57, 56

courses of OCD and OCPD,

54–55

family history linkage,

54

longitudinal studies of,

55

symptoms, core components and differential diagnosis of,

52–54

treatment implications,

57–59

panic disorders and,

13

perfectionism as feature of,

3, 12

personality traits and,

136

pharmacological treatment of

antiepileptics,

210

carbamazepine,

210

antipsychotics,

208–209

case vignette,

179–180

limitations and future directions of,

212–214

medication trials and case reports for OCPD diagnosis,

181

selective serotonin reuptake inhibitors,

180, 203–206

citalopram,

205–206

escitalopram,

206

fluvoxamine,

203–204

paroxetine,

205

sertraline,

204–205

serotonin-norepinephrine re-uptake inhibitors,

206–207

clovoxamine,

207

venlafaxine,

206–207

tricyclic antidepressants,

207–208

clomipramine,

207–208

imipramine,

208

positive aspects of,

233–243

career success and,

240, 241

case vignette,

233–234, 240–241

conscientiousness and resilience,

237–240

social and cognitive associations with,

234–236

prevalence in the general population,

145

psychobiology of,

127–142

case vignette,

127–128

dimensions of OCPD,

132–135

family studies,

128–129

molecular studies,

130–132

neuroimaging studies,

130–132

neurophychological studies,

129–130

proximal versus distal mechanisms,

135–136

psychotherapy

case vignette,

143–144, 150–165

POPS,

171, 172–176

research,

147–150

relapse prevention,

164–165

relationship to disorders with prominent impulsivity,

89–90

subgroups within,

148

sustained functional impairment and,

241

theoretical model of overlap between OCD, HD and,

56

traits in classification systems,

38–39

interpersonal functioning and,

146

perfectionism and,

146

phenomenology of,

40

treatment course,

156–165

CBT for clinical perfectionism and rigidity,

161–165

orientation,

157

STAIR treatment,

157–161, 159

Obsessive-compulsive personality traits (OCPTs),

129, 132

OCD

. See Obsessive-compulsive disorder

OCD Collaborative Genetics Study group,

31–32

OCPD

. See Obsessive-compulsive personality disorder

OCPTs

. See Obsessive-compulsive personality traits

OCRDs

. See Obsessive-compulsive and related disorders

OMNI

. See OMNI Personality Inventory

OMNI Personality Inventory (OMNI),

36

Oppositional defiant disorder, medication trial and case reports for OCPD and,

192

OSFED

. See Other specified feeding or eating disorder

Other specified feeding or eating disorder (OSFED),

78–79. See also Eating disorder not otherwise specified

Overconscientiousness, as feature of OCPD,

42

Panic disorder

medication trials and case reports for OCPD and,

192

with OCPD,

13

Parents

. See also Children; Marriage

attachment theory and parenting capacity,

221–223

definition of good parenting,

220–221

impact of parental personality disorder on child,

223–226

impact of personality disorders on parenting,

217–232

case vignette,

217–218

parenting deficits in people with personality disorders,

226–227

Parkinson’s disease, OCPD and,

131

Paroxetine

medication trials and case reports for OCPD

and compulsive buying,

197–198

and migraines,

193

and OCD,

189, 197–200

and vomiting,

193

for treatment of OCPD,

205, 211

Pathological Obsessive Compulsive Personality Scale (POPS),

14–15, 36, 154, 155

definitions and examples of,

171, 172–176

questionnaire,

173–176

scoring,

172

PDI

. See Personality Disorder Interview

PDQ

. See Personality Diagnostic Questionnaire

PDQ-4

. See Personality Diagnostic Questionnaire–4

Perfectionism,

214

case vignette,

143–144, 150–165

CBT model of clinical perfectionism,

156, 156–157

clinical perfectionism,

155–156

dimensions of,

17

as feature of OCPD,

3, 41, 146

interference with CBT for OCD,

59

maladaptive,

53, 65, 146

medication trial and case reports for OCPD and,

188

OCD treatment and,

58–59

with OCPD,

12

self-limiting,

165

socially prescribed,

146

Personality

brain structures and personality traits,

136

culture and,

117–118

gender and,

112–113

heritability of personality traits,

134

Personality Diagnostic Questionnaire (PDQ),

5, 207

Personality Diagnostic Questionnaire–4 (PDQ-4),

36

Personality Disorder Interview (PDI),

36

Personality disorders

culture and,

119–120

description of,

218

diagnostic criteria for,

114

DSM-5 definition of,

2

gender and,

113–114

genetics as risk factor for,

225–226

ICD-11 dimensional model of assessment,

2

impact of parental personality disorder on child,

223–226

impact on parenting,

217–232

impact on self and interpersonal functioning,

228

parenting and,

221–223. 226–227

research on,

227–228

Personality Inventory for the DSM-5 (PID-5),

37

Physical abuse,

225

PID-5

. See Personality Inventory for the DSM-5

PINK1

. See PTEN-induced kinase 1

POPS

. See Pathological Obsessive Compulsive Personality Scale

Preoccupation with details, order, and organization, as feature of OCPD,

41

Procrastination,

163, 166

Proteins, inflammatory proteins as biological feature of OCPD,

103, 104

Psychasthenic illness

development of,

3

state of,

51

Psychodynamic therapy

alternative psychotherapies for OCPD,

150

for treatment of OCPD with aggression,

106

PTEN-induced kinase 1 (PINK1),

131

Purging disorder,

78

Pyromania, rates of OCPD and,

90

Race

culture and,

120

DSM-5 definition of,

111–112

Radically Open Dialectical Behavior Therapy (RO-DBT),

150

Rapid Visual Information Processing test,

92

RAQ

. See Reciprocal Attachment Questionnaire

Reasons for Living Inventory,

146

Reciprocal Attachment Questionnaire (RAQ),

224

Resilience, conscientiousness and,

239–240

Rigidity,

17

definition of,

171

as feature of OCPD,

42

RO-DBT

. See Radically Open Dialectical Behavior Therapy

SAS-SR

. See Social Adjustment Scale—Self Report

Schedule for Nonadaptive and Adaptive Personality (SNAP),

16–17, 36, 238

Schizophrenia, medication trials and case reports for OCPD and,

190–191

SCID

. See Structured Clinical Interview for DSM-III-R Personality Disorders

SCID-II

. See Structured Clinical Interview for DSM-IV Axis II Personality Disorders

SCID-5-AMPD

. See Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders

SCID-5-PD

. See Structured Clinical Interview for DSM-5 Personality Disorders

SCID-5-SPQ

. See Structured Clinical Interview for DSM-5 Personality Disorders

SCID-I/P

. See Structured Clinical Interview for DSM-IV Axis I Disorders—Patient Version

Selective serotonin reuptake inhibitors (SSRIs),

131, 210, 214

Self,

118

impact of personality disorder on,

228

self-care,

167

self-compassion,

163–164

self-criticism,

163–164

self-evaluation,

164

Serotonin, as biomarker for aggression,

102–103

Serotonin-norepinephrine reuptake inhibitors (SNRIs), for treatment of OCPD,

206–207, 211

Serotonin reuptake inhibitor (SRI) medications, for treatment of OCD,

57

Serotonin transporter promoter polymorphism (5HTTLPR),

116–117

Sertraline

medication trials and case reports for OCPD

and AN,

186

and compulsive buying,

195, 197–198

and MDD,

183

and OCD,

196–201

and pathological gambling,

195, 197

and trichotillomania,

197

for treatment of OCPD,

204–205, 211

Sex

definition of,

111

versus gender,

111

Sexual abuse,

225

Sexual behavior

case vignette,

85–86, 93

compulsive,

89

rates of OCPD and,

90

treatment,

93

SIDP

. See Structured Interview, for DSM-IV Personality

SIDP-R

. See Structured Interview, for DSM-III-R Personality

sIL-1RII

. See Soluble interlukin-1 receptor II

Skills Training in Affective and Interpersonal Regulation (STAIR) treatment,

165

for OCPD,

151, 157–161, 159

Skin-picking disorder,

89

rates of OCPD and,

90

SNAP

. See Schedule for Nonadaptive and Adaptive Personality

SNRIs

. See Serotonin-norepinephrine reuptake inhibitors

Social Adjustment Scale—Self Report (SAS-SR),

153, 154

Socially prescribed perfectionism,

146

Soluble interlukin-1 receptor II (sIL-1RII),

103

SQ-Short

. See Systemizing Quotient Scale–Short

SRI

. See Serotonin reuptake inhibitor

SSRIs

. See Selective serotonin reuptake inhibitors

STAIR

. See Skills Training in Affective and Interpersonal Regulation treatment

Stop Signal Response Task,

92

Strange Situation test,

222

Structured Clinical Interview

for DSM-III-R Personality Disorders (SCID),

204

for DSM-IV Axis I Disorders—Patient Version (SCID-I/P),

152

for DSM-IV Axis II Personality Disorders (SCID-II),

5–6, 13, 15, 152

Personality Questionnaire,

15–16

for the DSM-5 Alternative Model for Personality Disorders (SCID-5-AMPD),

36–37

for DSM-5 Personality Disorders (SCID-5-PD),

36

for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ),

36

Structured Interview

for DSM-III-R Personality,

54

for DSM-IV Personality,

13

Stubbornness, as feature of OCPD,

42

Suicide, indicators for,

146

Systemizing Quotient Scale–Short (SQ-Short),

115

TCAs

. See Tricyclic antidepressants

Terman Life Cycle Study,

240

Thioridazine, medication trials and case reports for OCPD and schizophrenia,

190–191

Thiothixene, medication trial and case reports for OCPD and borderline and schizotypal personality disorders,

187

³H-PAROX

. See Tritiated paroxetine

Threshold versus dimensional models of OCPD,

16–18

Time management,

163, 166

Tourette’s disorder, medication trials and case reports for OCPD and,

194

Trichotillomania,

89

medication trials and case reports for OCPD and,

194, 197, 200

rates of OCPD and,

90

Tricyclic antidepressants (TCAs), for treatment of OCPD,

207–208, 211. See also individual drug names

Trier Social Stress Test (TSST),

131

Tritiated paroxetine (3H PAROX),

103

TSST

. See Trier Social Stress Test

Twin studies, of OCPD,

129

Venlafaxine

medication trial and case reports for OCPD and hoarding disorder,

182

for treatment of OCPD,

206–207

Wisconsin Personality Disorders Inventory–IV (WISPI-IV),

36

WISPI-IV

. See Wisconsin Personality Disorders Inventory–IV

Workaholic, as feature of OCPD,

41–42

Yale-Brown Obsessive Compulsive Scale (Y-BOCS),

52, 213

Y-BOCS

. See Yale-Brown Obsessive Compulsive Scale